Dual-target CAR-T cell therapy: latest updates from the 2025 ASH annual meeting
Abstract Dual-target chimeric antigen receptor T (CAR-T) cell therapy has emerged as a promising strategy to address the key limitations of single-target CAR-T approaches, including antigen heterogeneity and antigen-negative escape. Recent studies have reported rapid progress in the engineering of d...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BMC
2026-06-01
|
| Schriftenreihe: | Experimental Hematology & Oncology |
| Schlagworte: | |
| Online-Zugang: | https://doi.org/10.1186/s40164-026-00790-4 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|